Eligible candidates will reflect the National Science Foundation (NSF) definition of underrepresented populations in the US Biomedical, Clinical, Behavioral and Social Sciences Research Enterprise:
OR have a demonstrated commitment to increasing diverse patient participation in clinical trials.
Citizenship or immigration status
Eligible candidates will be US Citizens or Lawful Permanent Residents (LPRs) as defined by the US Department of Homeland Security. [NOTE: H-1B and O-1 Visa holders are eligible; the Visa must be valid during the full 2-yr period]
Eligible candidates will hold the degree of MD, MD/PhD, DO or DO/PhD
Eligible candidates will be Early-Stage Investigators (ESIs), defined by NIH as new investigators who have completed their terminal research degrees or medical residencies - whichever date is later - within the past 10 years and have not yet competed successfully for substantial NIH research grants. (Applicants with an RO1 or RO1 equivalent are ineligible.)
Letter of Intent (LOI) Submission Opened:
Oct 18, 2021
LOI Submission Closed:
Mar 15, 2022
Application Opened (By Invitation Only):
Jan 31, 2022
May 13, 2022
May 16 - Aug 1, 2022
Aug 2, 2022
Cohort 2 Begins:
Note: Dates are subject to change.
Visit our Informational Webinar page to view a recorded webinar!
Email the Winn CDA Team with any questions!
Copyright © 2022
Robert A. Winn Diversity in Clinical Trials Award Program. All Rights Reserved.